pdufa.bio

SKYRIZI (risankizumab-rzaa)

Updated ยทnext FDA decision on the calendar

SKYRIZI (risankizumab-rzaa) 1 FDA decision on record below. Every date links its source.

ABBV catalyst hub

About this program

We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

PDUFA · Jun 26, 2026 ✓ ApprovedABBV

Questions

When is SKYRIZI (risankizumab-rzaa)'s next FDA decision or readout?

No upcoming catalyst is on our calendar for SKYRIZI (risankizumab-rzaa); 1 FDA decision is on record below.

What happened at SKYRIZI (risankizumab-rzaa)'s most recent FDA decision?

On Jun 26, 2026 the FDA approved the application. The decision page carries the source document and the measured share-price reaction.